FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, has released the results of an independent survey of clinical laboratories’ diagnostic technology usage that identifies a critical need for improved understanding of clinical mass spectrometry technology. The worldwide survey investigated the most commonly used diagnostic methods, technologies and assay types, and identified a perceived lack of appreciation of the benefits of mass spectrometry, despite the proven advantages of this more accurate approach for clinical diagnostics. Findings from the report can be downloaded here.
Help employers find you! Check out all the jobs and post your resume.
